{"id":"W3123439150","doi":"10.1200/jco.2021.39.3_suppl.292","title":"Anlotinib plus TQB2450 in patients with advanced refractory biliary tract cancer (BTC): An open-label, dose-escalating, and dose-expansion cohort of phase Ib trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Gastroenterology; Cohort; Response Evaluation Criteria in Solid Tumors; Toxicity; Cancer; Refractory (planetary science); Adverse effect; Progressive disease; Oncology; Intrahepatic Cholangiocarcinoma; Phases of clinical research; Surgery; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001502082,0.001470297,0.00165537,0.000416909,0.00048764,0.001257358,0.000729276,0.0009455466,0.003647695],"category_scores_gemma":[0.0006035978,0.0004673694,0.001134935,0.0005205168,0.0006566328,0.0008627886,0.0004494335,0.002360007,0.001042294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001138492,"about_ca_system_score_gemma":0.001630502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001400777,"about_ca_topic_score_gemma":0.00358764,"domain_scores_codex":[0.9996736,0.0001355045,0.00001489261,0.00005868018,0.00003223883,0.00008503689],"domain_scores_gemma":[0.9994857,0.00004882554,0.00009113316,0.00003963436,0.00003362364,0.0003009786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7901914,0.07453019,0.01266476,0.0009164512,0.001295219,0.000377788,0.0003729904,0.003187678,0.03101391,0.0003099364,0.00598162,0.07915811],"study_design_scores_gemma":[0.6430981,0.324612,0.02266731,0.00004347287,0.0005731006,0.0004867948,0.00009882793,0.002104619,0.00239714,0.0002838753,0.003596796,0.00003798409],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933625,0.00102545,0.0002760859,0.0002649264,0.00006701839,0.002172569,0.001475218,0.0000636282,0.001292521],"genre_scores_gemma":[0.9868183,0.001379889,0.001354142,0.0006192184,0.0001573327,0.002713225,0.004177594,0.00002823019,0.002752096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003647695,"threshold_uncertainty_score":0.01220274,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1351391148446197,"score_gpt":0.4849624684913671,"score_spread":0.3498233536467473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}